Like I said here last night - the USA isn’t the only country in the world suffering high mortality rates due to COVID-19 ... IF Remestemcel-L actually proves its efficacy in the current COVID-19 ARDS trial then plenty of other countries will want it if the USA doesn’t .... the UK has just proven it is happy to cut the FDA’s lunch by approving the Pfizer COVID-19 vaccine before they did
https://www.cnbc.com/2020/12/02/uk-approves-pfizer-biontech-coronavirus-vaccine-for-use.html
UK approves Pfizer-BioNTech coronavirus vaccine, rollout due next week
- The vaccine will now be rolled out in the country next week, with elderly people in care homes and medical workers first in line.
- It makes Britain one of the first countries to begin vaccinating its population.
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial, page-300
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.025(2.22%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.19 | $1.13 | $8.289M | 7.186M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22569 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 105374 | 2 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.025 ( 2.46 %) |
||||
| Open | High | Low | Volume | ||
| $1.16 | $1.19 | $1.13 | 1229288 | ||
| Last updated 15.59pm 22/05/2024 ? | |||||
| MSB (ASX) Chart |